Recordati will acquire global rights to Enjaymo from Sanofi for $825M, boosting its rare disease portfolio. The deal includes ...
Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights ...
As Sanofi continues to clean out its medicine chest, Italy’s Recordati is getting in on the action. Recordati is floating $825 million upfront—plus another $250 million in potential commercial ...
(Reuters) -Italian pharma group Recordati said on Friday it would buy from Sanofi the global rights to ... the acquisition with existing cash and new committed bank debt facilities, expecting ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
MC: There is no old or new model, but there is old school thinking and open school thinking. We are clearly conscious of this within Sanofi and we truly believe that we will overcome the future ...
While Sanofi's list price of Aubagio is set at £13,529 ($22,100) per patient a year, NICE was able to recommend it for the NHS after Sanofi made the drug available at a discount under the patient ...
Starting this week off with a blackened masterclass. This is the perfect soundtrack to a morning ritual that involves painting your face and go out to windmill headbang in a forest. That's most of ...
Replacing cartilage is a stubborn problem, but new research shows a few potential paths forward. Millions of U.S. residents—perhaps up to 3 percent of the population—have an artificial hip ...
DALLAS, Oct. 3, 2024 /PRNewswire/ -- Senderra Specialty Pharmacy is pleased to announce the launch of our new Injection Training Video Library, now available in our website's "Injection Training ...
David Banks and Philip Banks III eclipsed their younger brother by rising to help run New York City. Then federal prosecutors seized the phones of all three men. By Joseph GoldsteinEliza Shapiro ...